Dulac Edward J III 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Dulac Edward J III（CIK 1821530）在 1 家公司共报告 5 笔 SEC Form 4 内部人交易（最近一笔 2026-07-24）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-24 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Financial Officer | 卖出 | 8,111 | $91,249 |
| 2026-07-06 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Financial Officer | 卖出 | 4,677 | $84,186 |
| 2026-03-03 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Financial Officer | 买入 | 61,280 | $0 |
| 2026-01-07 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Financial Officer | 卖出 | 6,379 | $58,751 |
| 2025-07-25 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Financial Officer | 卖出 | 7,462 | $104,617 |
来源：SEC Form 4 申报文件 · 截至 2026-07-24